Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Biogen reveals new cell adhesion inhibitor

April 16, 1997

New bladder-selective M3 antagonist reported by Yamanouchi

April 16, 1997

Potential BPH therapy from Abbott

April 16, 1997

Focus on sildenafil for erectile dysfunction

April 16, 1997

Optimal dose of sertraline for premature ejaculation

April 16, 1997

Placebo associated with improvement and side effects in treatment of BPH

April 16, 1997

GG-745 compared to finasteride in BPH patients

April 15, 1997

TGF-beta1 antisense vaccine effective in rat prostate cancer model

April 15, 1997

Furosemide vs. placebo for nocturnal polyuria

April 15, 1997

Nasal midazolam safe and effective for anterograde amnesia in children undergoing VCUG

April 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...